Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Immunol ; 206(10): 2402-2411, 2021 05 15.
Article de Anglais | MEDLINE | ID: mdl-33931485

RÉSUMÉ

Pneumococcal infections are common and serious complications of HIV-1 disease. Prevention has been compromised by the limited magnitude and quality of Ab responses to T cell-independent type 2 pneumococcal capsular polysaccharides (PPS). The pneumococcal polysaccharide-protein conjugate vaccine-13 (PCV-13) contains PPS conjugated to the T cell-dependent protein (diphtheria toxoid [DT] [CRM197]). We investigated the differential response to PPS and DT by human Ab-secreting B cells (ASC) after immunization with PCV-13 in newly diagnosed healthy HIV+ and control adults. The numbers of PPS-specific IgG ASC increased significantly and similarly in HIV+ and controls. However, DT-specific IgG ASC increased in controls but not HIV+ subjects. To determine the cellular basis of these disparate responses to DT and PPS, we characterized the frequency and activation of T follicular helper (Tfh) cells, the predominant T cell subset providing B cell help. Expression of inducible T cell costimulator (ICOS), which sustains Tfh function and phenotype, increased significantly among controls, when compared with the HIV+ group. Increases in ICOS+ Tfh correlated with changes in T-dependent, DT-specific IgG ASC in controls but not in HIV+ In contrast, ICOS expression did not correlate with T cell-independent type 2 PPS-specific ASC in either group. Of note, upon optimized ex vivo stimulation, CD4 T cells from HIV+ subjects differentiated into Tfh cells and formed synapses with Raji B cells at frequencies similar to that of controls. In summary, PCV-13-induced increase in ICOS expression on Tfh was associated with responses to DT, which was compromised in recently diagnosed healthy HIV+ adults and can be restored ex vivo by providing effective Tfh-differentiating signals.


Sujet(s)
Infections opportunistes liées au SIDA/prévention et contrôle , Immunité acquise , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Infections à pneumocoques/prévention et contrôle , Vaccins antipneumococciques/immunologie , Streptococcus pneumoniae/immunologie , Lymphocytes T auxiliaires folliculaires/immunologie , Vaccination/méthodes , Vaccins conjugués/immunologie , Infections opportunistes liées au SIDA/sang , Infections opportunistes liées au SIDA/immunologie , Infections opportunistes liées au SIDA/virologie , Adolescent , Adulte , Anticorps antibactériens/sang , Anticorps antibactériens/immunologie , Lymphocytes B/immunologie , Études cas-témoins , Femelle , Humains , Immunogénicité des vaccins , Protéine inductible de costimulation du lymphocyte T/métabolisme , Activation des lymphocytes , Mâle , Adulte d'âge moyen , Infections à pneumocoques/sang , Infections à pneumocoques/immunologie , Infections à pneumocoques/microbiologie , Résultat thérapeutique , Jeune adulte
2.
Protein Sci ; 26(3): 600-610, 2017 03.
Article de Anglais | MEDLINE | ID: mdl-28028839

RÉSUMÉ

IgA1 proteases (IgA1P) from diverse pathogenic bacteria specifically cleave human immunoglobulin A1 (IgA1) at the hinge region, thereby thwarting protective host immune responses. Streptococcus pneumoniae (S. pneumoniae) IgA1P shares no sequence conservation with serine or cysteine types of IgA1Ps or other known proteins, other than a conserved HExxH Zn-binding motif (1604-1608) found in metalloproteases. We have developed a novel expression system to produce the mature S. pneumoniae IgA1P and we have discovered that this form is both attached to the bacterial cell surface and released in its full form. Our data demonstrate that the S. pneumoniae IgA1P comprises two distinct regions that associate to form an active metalloprotease, the first such example of a metalloprotease that can be split in vitro and recombined to form an active enzyme. By capitalizing on this novel domain architecture, we show that the N-terminal region of S. pneumoniae IgA1P comprises the primary binding region for IgA1, although the C-terminal region of S. pneumoniae IgA1P is necessary for cleavage of IgA1. Our findings lend insight into the protein domain architecture of the S. pneumoniae IgA1P and function of this important virulence factor for S. pneumoniae infection.


Sujet(s)
Protéines bactériennes/composition chimique , Serine endopeptidases/composition chimique , Streptococcus pneumoniae/enzymologie , Facteurs de virulence/composition chimique , Motifs d'acides aminés , Catalyse , Domaines protéiques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE